Although the patient group was already selected for BRCA1 testing by positive family history of breast cancer that might include also presence of breast cancer in the individual there is a trend towards higher breast cancer frequency and incidence rate in mutation carriers. This evidence concerns the gene BRCA1 and breast carcinoma.